Trial Profile
Phase 2 Randomised Placebo Controlled Double Blind Study to Assess the Efficacy and Safety of Tecfidera in Patients with Amyotrophic Lateral Sclerosis (TEALS Study)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- Acronyms TEALS Study
- 01 Feb 2020 Study design published in the Medicine.
- 01 Feb 2020 Status changed from not yet recruiting to recruiting, as per Study design published in the Medicine.
- 11 Apr 2018 New trial record